Milatuzumab, CAS [[899796-83-9]]

Produktübersicht

• Artikelname: Milatuzumab, CAS [[899796-83-9]]
• Artikelnummer: MCE-HY-P99731
• Hersteller Artikelnummer: HY-P99731
• Alternativnummer: MCE-HY-P99731-5MG,MCE-HY-P99731-25MG,MCE-HY-P99731-1MG,MCE-HY-P99731-10MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: hLL1, MEDI-115

Produktbeschreibung

Milatuzumab (hLL1, MEDI-115) is a humanized anti-CD74 monoclonal antibody. CD74, a integral membrane protein, is associated with the promotion of B-cell growth and survival. Milatuzumab causes free radical oxygen generation, and loss of mitochondrial membrane potential. Milatuzumaba also decreases CD20/CD74 aggregates and cell adhesion, to lead to cell death[1].

Produkteigenschaften

• Molekulargewicht: (145.66 kDa)
• Reinheit: 99.39
• CAS Nummer: [899796-83-9]
• Target-Kategorie: CD74

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies